Tuesday, December 06, 2022 3:25:05 PM
That would be HUGE for the trial, because today's SOC is pretty darn good compared to two years ago. Last month I caught COVID for the first time (I'm in my 60s) and I was pretty damn sick on day 1!! But I immediately started popping those paxlovid pills and by day 3 COVID was completely behind me. So the SOC for me last month with that pill was very, very good. But one has to get on that pill asap and not wait several days for the virus to take a deep hold. Having said that, I could have been one of the positive outliers with that SOC.
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
